News headlines about ContraFect Corp (NASDAQ:CFRX) have trended somewhat positive on Saturday, Alpha One reports. Alpha One, a subsidiary of Accern, ranks the sentiment of press coverage by analyzing more than twenty million news and blog sources in real time. Alpha One ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. ContraFect Corp earned a news impact score of 0.22 on Alpha One’s scale. Alpha One also assigned news stories about the biotechnology company an impact score of 12 out of 100, indicating that recent press coverage is very unlikely to have an effect on the company’s share price in the next several days.
ContraFect Corp (NASDAQ:CFRX) opened at 1.25 on Friday. The company’s market capitalization is $52.07 million. The firm has a 50-day moving average of $1.63 and a 200-day moving average of $1.93. ContraFect Corp has a 52 week low of $1.20 and a 52 week high of $3.40.
ContraFect Corp (NASDAQ:CFRX) last posted its earnings results on Monday, May 8th. The biotechnology company reported ($0.15) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.17) by $0.02. Analysts anticipate that ContraFect Corp will post ($0.71) EPS for the current fiscal year.
Separately, Maxim Group reiterated a “hold” rating on shares of ContraFect Corp in a report on Wednesday, April 19th.
Receive News & Ratings for ContraFect Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ContraFect Corp and related companies with MarketBeat.com's FREE daily email newsletter.